10x Genomics, Inc.
TXG
$11.11
-$0.5895-5.04%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.81% | -0.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.81% | -0.95% | |||
| Cost of Revenue | 19.45% | -7.41% | |||
| Gross Profit | 4.29% | 2.09% | |||
| SG&A Expenses | 14.84% | -1.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.25% | -0.87% | |||
| Operating Income | -20.14% | 0.60% | |||
| Income Before Tax | -40.48% | 7.12% | |||
| Income Tax Expenses | -50.72% | 60.76% | |||
| Earnings from Continuing Operations | -37.13% | 5.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.13% | 5.66% | |||
| EBIT | -20.14% | 0.60% | |||
| EBITDA | -26.35% | 0.75% | |||
| EPS Basic | -36.17% | 6.18% | |||
| Normalized Basic EPS | -39.48% | 7.62% | |||
| EPS Diluted | -36.17% | 6.18% | |||
| Normalized Diluted EPS | -39.48% | 7.62% | |||
| Average Basic Shares Outstanding | 0.72% | 0.55% | |||
| Average Diluted Shares Outstanding | 0.72% | 0.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
